GI001 is a sativa-dominant cannabis cultivar developed by Growth Industries’ botanists. The plant exhibits a lime-green hue and delivers a citrus-forward flavor, with high yields achievable under standard cultivation practices.
Its effects are characterized by little to no psychoactivity, making it a practical daytime option for users who want relief without interference with daily activities. The strain maintains a CBD to THC ratio of 24:1 consistently, reflecting Growth Industries’ commitment to medical-grade cultivation policies and procedures.
Access to GI001 is restricted to authorized vendors and pharmaceutical raw material outlets, aligning with a regulated supply chain. Within medical contexts, its prominent CBD content, predictable potency, and controlled production framework position GI001 as a dependable daytime therapeutic option.